Literature DB >> 8392552

The mechanism for the rapid desensitization in bradykinin-stimulated inositol monophosphate production in NG108-15 cells involves interaction of a single receptor with multiple signaling pathways.

D H Wolsing1, J S Rosenbaum.   

Abstract

We have previously shown that the mechanism for the rapid desensitization in bradykinin (BDK)-stimulated inositol monophosphate (IP) production in NG108-15 cells involves both a rapid loss of receptors from the cell surface and an uncoupling of the receptor:G-protein:phospholipase C (PLC) signaling process, with protein kinase C (PKC) activation playing a role only at a postreceptor level (Wolsing and Rosenbaum, 1991). In contrast to BDK, a 5-min pretreatment with the BDK receptor "antagonist" NPC-567 is sufficient to cause a substantial decrease in the subsequent BDK maximal response (Emax) without altering either the BDK potency (EC50) or the BDK receptor number. An 18-hr pretreatment of the cells with 200 ng/ml pertussis toxin (PT) does not alter the BDK response (Fold stim = 2.36 +/- 0.18 vs. 2.00 +/- 0.25 in controls, N = 4), reiterating previous observations that BDK-stimulated IP production in this cell line is mediated by a pertussis toxin (PT)-insensitive G-protein. However, PT pretreatment significantly (P < .05) attenuates the receptor loss that accompanies the desensitization process. Taken together, these data imply that the BDK receptor in NG108-15 cells interacts with both PT-sensitive and PT-insensitive G-proteins. Because NPC-567 pretreatment results in a desensitization that is not accompanied by receptor loss, it appears that NPC-567 is able to facilitate an agonistic interaction with only the PT-insensitive G-proteins that are available to the receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392552

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

Review 1.  Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins.

Authors:  T A Fields; P J Casey
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

Review 2.  Contribution of pertussis toxin to the pathogenesis of pertussis disease.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2015-09-21       Impact factor: 3.166

3.  Bradykinin B2 receptor-induced and inositol tetrakisphosphate-evoked Ca2+ entry is sensitive to a protein tyrosine phosphorylation inhibitor in ras-transformed NIH/3T3 fibroblasts.

Authors:  M Hashii; S Nakashima; S Yokoyama; K Enomoto; Y Minabe; Y Nozawa; H Higashida
Journal:  Biochem J       Date:  1996-10-15       Impact factor: 3.857

Review 4.  Coughing precipitated by Bordetella pertussis infection.

Authors:  Matthew Hewitt; Brendan J Canning
Journal:  Lung       Date:  2010-01       Impact factor: 2.584

5.  Cyclic GMP regulates activation of phosphoinositidase C by bradykinin in sensory neurons.

Authors:  J S Harvey; G M Burgess
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

6.  Pharmacology of Bradykinin-Evoked Coughing in Guinea Pigs.

Authors:  Matthew M Hewitt; Gregory Adams; Stuart B Mazzone; Nanako Mori; Li Yu; Brendan J Canning
Journal:  J Pharmacol Exp Ther       Date:  2016-03-21       Impact factor: 4.030

7.  Involvement of B1 and B2 receptors in bradykinin-induced rat paw oedema.

Authors:  M M Campos; J B Calixto
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

8.  Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems.

Authors:  S Robb; T R Cheek; F L Hannan; L M Hall; J M Midgley; P D Evans
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

Review 9.  Association of Pertussis Toxin with Severe Pertussis Disease.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Toxins (Basel)       Date:  2019-06-27       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.